Transient Memory Impairment and Hallucinations Associated with Tolterodine Use [8]

New England Journal of Medicine

Volumn 349, Issue 23, 2003, Pages 2274-2275

  Tsao, Jack W ^a   Heilman, Kenneth M ^b  

^a NAVAL HOSPITAL JACKSONVILLE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DONEPEZIL; TOLTERODINE;

AGED; CASE REPORT; CLINICAL FEATURE; DEMENTIA; FEMALE; HALLUCINATION; HUMAN; LEARNING; LETTER; MEDICAL EXAMINATION; MEMORY DISORDER; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RECALL; TREATMENT OUTCOME; URINE INCONTINENCE;

AGED; BENZHYDRYL COMPOUNDS; CRESOLS; FEMALE; HALLUCINATIONS; HUMANS; MEMORY DISORDERS; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; URINARY INCONTINENCE;

EID: 0344874652     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200312043492325     Document Type: Letter

References (5)

1. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Neurology 1999;53:902-5.
2. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test - revised: normative data and analysis of interform and test-retest reliability. Clin Neuropsychol 1998;12:43-55.
3. Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA III, Murphy DL. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls: a dose-response study. Arch Gen Psychiatry 1987;44:418-26.
4. Womack KB, Heilman KM. Tolterodine and memory: dry but forgetful. Arch Neurol 2003;60:771-3.
5. Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol 2003;54:235-8.